Filing Flows › Companies › Elevance Health › Timeline
Elevance Health stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+38.1% to $425.62
Elevance Health (ELV) stock rose 38% over the last 252 sessions, to $425.62. On the way it reported 0 quarters, its insiders filed 3 open-market trades and 3 Form 144 notices of planned sales, and the company filed 2 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 5, 2026 | Form 144 | Form 144: Ratnakar Lavu plans to sell $572K | −0.5% (+4.0% vs SPY) | — | — |
| Nov 5, 2026 | Insider sale | Lavu Ratnakar sold $572K | −0.5% (+4.0% vs SPY) | — | — |
| Oct 22, 2026 | Form 144 | Form 144: Mark B Kaye plans to sell $4.7M | +2.5% (+3.7% vs SPY) | −4.6% (−4.5% vs SPY) | — |
| Jul 17, 2026 | Insider buy | Peru Ramiro G bought $366K | +0.1% (+1.1% vs SPY) | +1.7% (+3.4% vs SPY) | +7.1% (+3.7% vs SPY) |
| Jul 17, 2026 | Insider buy | Boudreaux Gail bought $1.0M | +0.1% (+1.1% vs SPY) | +1.7% (+3.4% vs SPY) | +7.1% (+3.7% vs SPY) |
| Jul 7, 2026 | Form 144 | Form 144: R Kerry Clark plans to sell $630K | +2.6% (+3.1% vs SPY) | +4.1% (+4.4% vs SPY) | −7.7% (−10.3% vs SPY) |
| Feb 26, 2026 | 8-K | Directors and officers: departures, appointments, pay | −2.3% (−1.7% vs SPY) | −12.6% (−11.4% vs SPY) | −11.0% (−4.1% vs SPY) |
| Dec 10, 2025 | 8-K | Directors and officers: departures, appointments, pay | +5.5% (+5.2% vs SPY) | +1.4% (+3.8% vs SPY) | +9.5% (+8.1% vs SPY) |
Insiders’ record here
In the year on the chart, Elevance Health's insiders reported 2 open-market buys ($1.4M) and 1 sale ($572K). Of the 2 old enough to score, 2 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was +11.0% and after a sale —.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Elevance Health: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.